New York State Common Retirement Fund’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47K | Hold |
12,543
| – | – | ﹤0.01% | 2956 |
|
|
2025
Q1 | $41K | Hold |
12,543
| – | – | ﹤0.01% | 2841 |
|
|
2024
Q4 | $70K | Sell |
12,543
-3,100
| -20% | -$17.3K | ﹤0.01% | 2740 |
|
|
2024
Q3 | $169K | Sell |
15,643
-5,400
| -26% | -$58.3K | ﹤0.01% | 2377 |
|
|
2024
Q2 | $442K | Buy |
21,043
+3,868
| +23% | +$81.2K | ﹤0.01% | 2090 |
|
|
2024
Q1 | $547K | Sell |
17,175
-2,247
| -12% | -$71.6K | ﹤0.01% | 2040 |
|
|
2023
Q4 | $393K | Buy |
19,422
+5,609
| +41% | +$113K | ﹤0.01% | 2191 |
|
|
2023
Q3 | $176K | Buy |
13,813
+197
| +1% | +$2.51K | ﹤0.01% | 2481 |
|
|
2023
Q2 | $246K | Sell |
13,616
-2,545
| -16% | -$46K | ﹤0.01% | 2401 |
|
|
2023
Q1 | $278K | Sell |
16,161
-3,473
| -18% | -$59.7K | ﹤0.01% | 2455 |
|
|
2022
Q4 | $436K | Sell |
19,634
-27
| -0.1% | -$600 | ﹤0.01% | 2379 |
|
|
2022
Q3 | $158K | Buy |
19,661
+9,956
| +103% | +$80K | ﹤0.01% | 2853 |
|
|
2022
Q2 | $68K | Sell |
9,705
-13,239
| -58% | -$92.8K | ﹤0.01% | 3188 |
|
|
2022
Q1 | $347K | Buy |
22,944
+8,570
| +60% | +$130K | ﹤0.01% | 2570 |
|
|
2021
Q4 | $315K | Buy |
14,374
+4,879
| +51% | +$107K | ﹤0.01% | 2684 |
|
|
2021
Q3 | $256K | Buy |
9,495
+1,734
| +22% | +$46.8K | ﹤0.01% | 2811 |
|
|
2021
Q2 | $187K | Buy |
7,761
+4,261
| +122% | +$103K | ﹤0.01% | 3066 |
|
|
2021
Q1 | $152K | Buy |
+3,500
| New | +$152K | ﹤0.01% | 2932 |
|